Comparison of Betaferon®, Avonex® and Rebif® in treatment of relapsing-remitting multiple sclerosis

被引：0

作者：

Shaygannejad, V. ^{[1
]}

Etemadifar, M. ^{[1
]}

Fereshteh, A. ^{[1
]}

机构：

[1] Isfahan Univ, Esfahan, Iran

来源：

MULTIPLE SCLEROSIS | 2006年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S200 / S200

页数：1

共 50 条

[11] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis
Miller, Aaron E.
[J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (02) : 181 - 194
[12] Ponesimod for the treatment of relapsing-remitting multiple sclerosis
Gaber, Tarek A-Z K.
Eltemamy, Marwa
[J]. PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2022, 26 (02) : 18 - 19
[13] Quality of life assessment of relapsing-remitting multiple sclerosis patients on long-term treatment with Betaferon
Davidescu, I.
Damian, G.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 129 - 129
[14] Relapsing-remitting multiple sclerosis
Flores, A
Ochoa, E
Zamora, S
Barrientos, UN
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
[15] Quality of life in relapsing-remitting multiple sclerosis patients receiving CinnoVex compared with Avonex
Hatam, Nahid
Bastani, Peivand
Shahtaheri, Rahil Sadat
[J]. JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2016, 5 (03) : 181 - 185
[16] Risk Factors for Poor Adherence to Betaferon® Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Syndrome
Jernas, Lukasz
Wencel, Jacek
Wiak, Andrzej
Bieniek, Marek
Bartosik-Psujek, Halina
[J]. PLOS ONE, 2016, 11 (10):
[17] Immunomodulatory treatment of relapsing-remitting multiple sclerosis - the ASSET (Avonex Assessment in Multiple Sclerosis Therapy) study, an observational study in 1354 patients
Marziniak, M.
Graf, T.
Niemczyk, G.
Rehberg-Weber, K.
[J]. JOURNAL OF NEUROLOGY, 2012, 259 : S113 - S114
[18] Oral laquinimod for treatment of relapsing-remitting multiple sclerosis
Weiner, Howard L.
[J]. LANCET NEUROLOGY, 2008, 7 (08): : 672 - 673
[19] Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis
Ingwersen, Jens
Aktas, Orhan
Hartung, Hans-Peter
[J]. NEUROTHERAPEUTICS, 2016, 13 (01) : 47 - 57
[20] ORAL FINGOLIMOD FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS
Vosiliou, S.
[J]. DRUGS OF TODAY, 2010, 46 (05) : 315 - 325

← 1 2 3 4 5 →